Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 3
1934 1
1936 1
1944 1
1945 1
1946 3
1947 2
1948 1
1949 4
1950 1
1951 2
1952 3
1953 4
1954 2
1956 2
1957 3
1958 3
1960 1
1961 1
1963 5
1964 1
1965 7
1966 5
1967 2
1968 4
1969 3
1970 2
1971 4
1972 3
1973 3
1974 1
1975 1
1976 2
1977 3
1979 3
1980 2
1981 6
1982 4
1983 1
1984 8
1985 9
1986 2
1988 1
1989 3
1990 6
1991 2
1992 3
1993 3
1994 2
1995 3
1996 7
1997 4
1998 12
1999 7
2000 8
2001 9
2002 8
2003 8
2004 11
2005 17
2006 9
2007 20
2008 22
2009 23
2010 22
2011 17
2012 23
2013 27
2014 20
2015 45
2016 45
2017 43
2018 40
2019 46
2020 52
2021 44
2022 39
2023 33
2024 35
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

751 results

Results by year

Filters applied: . Clear all
Page 1
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grünig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ; AMBITION Investigators. Galiè N, et al. Among authors: peacock aj. N Engl J Med. 2015 Aug 27;373(9):834-44. doi: 10.1056/NEJMoa1413687. N Engl J Med. 2015. PMID: 26308684 Free article. Clinical Trial.
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Hoeper MM, Al-Hiti H, Benza RL, Chang SA, Corris PA, Gibbs JSR, Grünig E, Jansa P, Klinger JR, Langleben D, McLaughlin VV, Meyer GMB, Ota-Arakaki J, Peacock AJ, Pulido T, Rosenkranz S, Vizza CD, Vonk-Noordegraaf A, White RJ, Chang M, Kleinjung F, Meier C, Paraschin K, Ghofrani HA, Simonneau G; REPLACE investigators. Hoeper MM, et al. Among authors: peacock aj. Lancet Respir Med. 2021 Jun;9(6):573-584. doi: 10.1016/S2213-2600(20)30532-4. Epub 2021 Mar 24. Lancet Respir Med. 2021. PMID: 33773120 Clinical Trial.
What's New in Pigmentary Disorders.
Zubair R, Lyons AB, Vellaichamy G, Peacock A, Hamzavi I. Zubair R, et al. Among authors: peacock a. Dermatol Clin. 2019 Apr;37(2):175-181. doi: 10.1016/j.det.2018.12.008. Epub 2019 Feb 16. Dermatol Clin. 2019. PMID: 30850040 Review.
The Right Heart-Pulmonary Circulation Unit: Physiopathology.
Naeije R, Vanderpool R, Peacock A, Badagliacca R. Naeije R, et al. Among authors: peacock a. Heart Fail Clin. 2018 Jul;14(3):237-245. doi: 10.1016/j.hfc.2018.02.001. Heart Fail Clin. 2018. PMID: 29966623 Review.
Treatment of pulmonary hypertension.
Peacock AJ; National Pulmonary Hypertension Services of UK and Ireland. Peacock AJ, et al. BMJ. 2003 Apr 19;326(7394):835-6. doi: 10.1136/bmj.326.7394.835. BMJ. 2003. PMID: 12702599 Free PMC article. No abstract available.
751 results